Biotechnology Two sick children and a $1.5 million bill: One family’s race for a gene therapy cure One day, gene therapy may help with the rarest of diseases. Some parents aren’t waiting. by Antonio Regalado 2018-10-23T05:00:00-04:00
Biotechnology Fast genome tests are diagnosing some of the sickest babies in time to save them Rapid DNA sequencing is helping doctors treat critically ill infants in days rather than weeks. by Emily Mullin 2018-03-08T10:24:00-05:00
Biotechnology CRISPR in 2018: Coming to a Human Near You The first clinical trials are slated to begin in the U.S. and Europe while others are stalled. by Emily Mullin 2017-12-18T00:00:00-05:00
Rewriting Life A New Gene-Editing Therapy Would Benefit Kids Most—Here’s Why They Won’t Get It Yet Children are often barred from initial clinical trials, even when a treatment might save their lives. by Emily Mullin 2017-11-16T15:35:00-05:00
Rewriting Life Gene-Therapy Grafts Have Repaired a Child’s Devastating Skin Disorder The transplant, carried out in Germany, replaced almost all of a patient’s skin. by Emily Mullin 2017-11-08T13:57:00-05:00
Biotechnology CRISPR 2.0 Is Here, and It’s Way More Precise It could one day be used to treat a range of inherited diseases. by Emily Mullin 2017-10-25T13:00:00-04:00
Biotechnology Arming Bodies with CRISPR to Fight Huntington’s Disease and ALS The editing tool normally targets DNA, but scientists are aiming it at a different molecule. by Emily Mullin 2017-10-05T15:45:00-04:00
Rewriting Life DNA Testing Reveals the Chance of Bad News in Your Genes For healthy people, the value of genome sequencing is still unclear. by Emily Mullin 2017-06-26T18:09:00-04:00
Rewriting Life The World’s Most Expensive Medicine Is Being Pulled from the Market The maker of the gene therapy Glybera says it doesn’t have enough customers. by Emily Mullin 2017-04-21T16:36:00-04:00
Biotechnology When Even Genome Sequencing Doesn’t Give a Diagnosis The technology has been touted as a powerful diagnostic tool, but it doesn’t provide answers to everyone. by Emily Mullin 2017-04-21T00:00:00-04:00
